Jiangsu Hengrui Medicine is an API manufacturer based in China. It appears in 13 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), MINSA (CR) and EDA (EG).
| Site | FDA FEI |
|---|---|
| Lianyungang, China | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Atracurium Besylate | SFDA (Saudi Arabia) | 1 |
| Cisatracurium | SFDA (Saudi Arabia) | 1 |
| Docetaxel | SFDA (Saudi Arabia) | 1 |
| Ifosfamide | SFDA (Saudi Arabia) | 1 |
| Oxaliplatin | SFDA (Saudi Arabia) | 1 |
| Sevoflurane | SFDA (Saudi Arabia) | 1 |
| Tolvaptan | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 5 | None |
| MINSA (CR) | 4 | None |
| EDA (EG) | 2 | None |
| INVIMA (CO) | 1 | None |
| UZPHARM (UZ) | 1 | None |
Choose your molecules and target markets. Jiangsu Hengrui Medicine comes back tiered against every other supplier able to file there.
Start for free